BACE1 and Alzheimer disease: The molecular docking verification and molecular dynamics simulation demonstrated that the predicted natural products scoulerine and genistein displayed strong binding affinities with BACE1 and ESR1, respectively, indicating these two natural products (with high druggability) are potential AD drugs.